BLB&B Advisors’s Organon & Co OGN Stock Holding History

BLB&B Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,948	Closed	-$228K	–	267
2021 Q3	$228K	Buy	6,948 +132	+2%	+$4.22K	0.02%	257
2021 Q2	$206K	Buy	+6,816	New	+$224K	0.01%	250

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BLB&B Advisors's OGN Position: Q4 2021 in Review

BLB&B Advisors sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 6,948 shares — an estimated $228K sold.

BLB&B Advisors first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $228K in Q3 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

BLB&B Advisors reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
BLB&B Advisors sold 6,948 Organon & Co shares in Q4 2021, an estimated $228K.
BLB&B Advisors first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
BLB&B Advisors's Organon & Co position peaked at $228K in Q3 2021.
907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on BLB&B Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.